GINS2 and ovarian carcinoma: It was found that low mRNA expression of MCM3 (HR 0.75 [0.58–0.97], P = 0.027) was associated with worse overall survival for ovarian cancer patients, as well as GINS2 (HR 0.75 [0.58–0.97], P = 0.026) (Fig. 9).